Lesson 01
Incomplete
From Lab to Clinic: The Drug Development Pipeline
Most drug candidates fail before a single patient is enrolled, and the ones that reach trials have already survived a decade of attrition.
Open lesson →Biotech
Clinical Trials & Drug Development
Understand how drugs move from discovery to market so you can ask the questions that reveal real risk and timeline assumptions.
4 lessons · 52 minutes · Beginner
Lesson 02
Incomplete
Understanding Clinical Trial Phases & Regulatory Pathways
Phase 3 success does not mean approval, and FDA approval does not mean the drug makes it to patients — the pathway between them is where most programs stall.
Open lesson →Lesson 03
Incomplete
Trial Design, Patient Recruitment & Data Collection
A trial that cannot enroll its patients on time will not produce data that wins approval, regardless of how good the drug is.
Open lesson →Lesson 04
Incomplete
FDA Approval, Reimbursement & Market Entry
FDA approval is the beginning of a commercial problem, not the end of a regulatory one — and most drug programs are not financially ready for what comes next.
Open lesson →